The effects of perindopril on aortic elasticity and infl ammatory markers in hypertensive patients

Medical Science Monitor

Volumn 15, Issue 7, 2009, Pages

  Koz, Cem ^a   Baysan, Oben ^a   Yokusoglu, Mehmet ^a   Uzun, Mehmet ^a   Yildirim, Mustafa ^a   Hasimi, Adnan ^a   Oz, Bilgehan Savas ^a   Erinc, Kursad ^a   Karaeren, Hayrettin ^a   Celebi, Huseyin ^a   Isik, Ersoy ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Aortic elasticity; Inflammatory markers; Perindopril

Indexed keywords

ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; PERINDOPRIL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AORTA FLOW; AORTIC STIFFNESS INDEX; ARTERIAL STIFFNESS; ARTERY DILATATION; ARTICLE; ATHEROSCLEROSIS; DISEASE MARKER; ELASTICITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; STRESS STRAIN RELATIONSHIP;

ANTIHYPERTENSIVE AGENTS; AORTA; BIOLOGICAL MARKERS; ELASTICITY; FEMALE; HUMANS; HYPERTENSION; INFLAMMATION; MALE; MIDDLE AGED; PERINDOPRIL;

EID: 67650653275     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Sesso HD, Buring JE, Rifai N et al: C-reactive protein and the risk of developing hypertension. JAMA, 2003; 290: 2945-2951 (Pubitemid 37505526)
2. Ross R: Atherosclerosis - an infl ammatory disease. N Engl J Med, 1999; 340: 115-126
3. Bautista LE: Infl ammation, endothelial dysfunction, and the risk of high blood pressure: epidemiologic and biological evidence. J Hum Hypertens, 2003; 17: 223-230 (Pubitemid 36592013)
4. Bautista LE: Association of C-reactive protein with blood pressure. Arterioscler Thromb Vasc Biol, 2005; 25: e137
5. King DE, Egan BM, Mainous AG III, Geesey ME: Elevation of C-reactive protein in people with prehypertension. J Clin Hypertens (Greenwich), 2004; 6: 562-568
6. Chrysohoou C, Pitsavos C, Panagiotakos DB et al: Association between prehypertension status and infl ammatory markers related to atherosclerotic disease: The ATTICA Study. Am J Hypertens, 2004; 17: 568-573 (Pubitemid 38844982)
7. Nurnberger J, Kefl ioglu-Scheiber A, Opazo Saez AM et al: Augmentation index is associated with cardiovascular risk. J Hypertens, 2002; 20: 2407-2414
8. Benetos A, Rudnichi A, Safar M, Guize L: Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. Hypertension, 1998; 32: 560-564 (Pubitemid 28429149)
9. O'Rourke MF, Gallagher DE: Pulse wave analysis. J Hypertens Suppl, 1996; 14: S147-57
10. Mattace-Raso FU, van der Cammen TJ, van der Meer IM et al: C-reactive protein and arterial stiffness in older adults: the Rotterdam Study. Atherosclerosis, 2004; 176: 111-116 (Pubitemid 39078652)
11. Asmar RG, Pannier B, Santoni JP et al: Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension. Circulation, 1988; 78: 941-950 (Pubitemid 18247617)
12. Zhuo JL, Mendelsohn FA, Ohishi M: Perindopril alters vascular angiotensin- converting enzyme, AT(1) receptor, and nitric oxide synthase expression in patients with coronary heart disease. Hypertension, 2002; 39(2 Pt 2): 634-638
13. Kranzhofer R, Schmidt J, Pfeiffer CA et al: Angiotensin induces infl ammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol, 1999; 19: 1623-1629 (Pubitemid 29323820)
14. Stratos C, Stefanadis C, Kallikazaros I et al: Ascending aorta distensibility abnormalities in hypertensive patients and response to nifedipine administration. Am J Med, 1992; 93: 505-512